Mainstream

CARGO Therapeutics to be acquired by Concentra Biosciences in $4.379/share cash deal plus CVR; stock rises 8%

CARGO Therapeutics to be acquired by Concentra Biosciences in $4.379/share cash deal plus CVR; stock rises 8%

Post ContentcrgxRead More

You might also be interested in reading Exploited Cross-Chain Protocol Nomad Offers Hackers 10% To Return Stolen $190 Million.

July 8, 2025
In Mainstream